Morgan Stanley’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$854M Sell
12,216,669
-3,551,867
-23% -$248M 0.06% 326
2025
Q1
$1.16B Sell
15,768,536
-1,532,553
-9% -$113M 0.08% 218
2024
Q4
$1.13B Buy
17,301,089
+4,476,178
+35% +$293M 0.08% 218
2024
Q3
$999M Buy
12,824,911
+424,600
+3% +$33.1M 0.07% 252
2024
Q2
$967M Sell
12,400,311
-2,700,836
-18% -$211M 0.07% 235
2024
Q1
$1.02B Sell
15,101,147
-9,959,173
-40% -$675M 0.08% 226
2023
Q4
$1.69B Buy
25,060,320
+11,798,615
+89% +$795M 0.07% 247
2023
Q3
$898M Sell
13,261,705
-244,056
-2% -$16.5M 0.09% 212
2023
Q2
$967M Buy
13,505,761
+553,713
+4% +$39.6M 0.1% 203
2023
Q1
$899M Buy
12,952,048
+2,729,451
+27% +$189M 0.1% 212
2022
Q4
$693M Buy
10,222,597
+1,561,194
+18% +$106M 0.08% 252
2022
Q3
$475M Buy
8,661,403
+273,794
+3% +$15M 0.06% 287
2022
Q2
$554M Buy
8,387,609
+5,284,956
+170% +$349M 0.07% 260
2022
Q1
$206M Sell
3,102,653
-79,580
-3% -$5.28M 0.03% 519
2021
Q4
$185M Sell
3,182,233
-1,242,918
-28% -$72.4M 0.02% 599
2021
Q3
$266M Buy
4,425,151
+102,041
+2% +$6.13M 0.04% 442
2021
Q2
$259M Buy
4,323,110
+2,068,480
+92% +$124M 0.03% 451
2021
Q1
$112M Sell
2,254,630
-246,209
-10% -$12.2M 0.02% 706
2020
Q4
$125M Sell
2,500,839
-1,627,457
-39% -$81.4M 0.02% 622
2020
Q3
$226M Buy
4,128,296
+377,780
+10% +$20.7M 0.04% 350
2020
Q2
$198M Buy
3,750,516
+1,521,616
+68% +$80.5M 0.04% 355
2020
Q1
$99.5M Sell
2,228,900
-7,326
-0.3% -$327K 0.03% 490
2019
Q4
$111M Buy
2,236,226
+5,953
+0.3% +$297K 0.03% 564
2019
Q3
$99.4M Sell
2,230,273
-201,619
-8% -$8.99M 0.03% 562
2019
Q2
$100M Sell
2,431,892
-5,001,995
-67% -$206M 0.03% 554
2019
Q1
$301M Buy
7,433,887
+5,204,220
+233% +$210M 0.09% 249
2018
Q4
$84.7M Sell
2,229,667
-229,791
-9% -$8.73M 0.03% 583
2018
Q3
$97.3M Buy
2,459,458
+127,216
+5% +$5.03M 0.02% 609
2018
Q2
$81.9M Sell
2,332,242
-122,056
-5% -$4.29M 0.02% 669
2018
Q1
$85.8M Buy
2,454,298
+15,788
+0.6% +$552K 0.02% 654
2017
Q4
$84.6M Buy
2,438,510
+132,102
+6% +$4.58M 0.02% 666
2017
Q3
$78.1M Sell
2,306,408
-195,769
-8% -$6.63M 0.02% 681
2017
Q2
$85.3M Buy
2,502,177
+85,199
+4% +$2.9M 0.03% 630
2017
Q1
$75.3M Buy
2,416,978
+168,279
+7% +$5.24M 0.02% 700
2016
Q4
$61.4M Sell
2,248,699
-187,980
-8% -$5.14M 0.02% 762
2016
Q3
$80.1M Buy
2,436,679
+321,682
+15% +$10.6M 0.03% 618
2016
Q2
$63.9M Buy
2,114,997
+129,737
+7% +$3.92M 0.02% 678
2016
Q1
$55.9M Buy
1,985,260
+412,872
+26% +$11.6M 0.02% 700
2015
Q4
$53.4M Buy
1,572,388
+220,787
+16% +$7.5M 0.02% 749
2015
Q3
$43M Buy
1,351,601
+44,041
+3% +$1.4M 0.02% 880
2015
Q2
$41.7M Sell
1,307,560
-85,826
-6% -$2.73M 0.01% 974
2015
Q1
$47.7M Sell
1,393,386
-395,028
-22% -$13.5M 0.02% 883
2014
Q4
$62.9M Sell
1,788,414
-1,893,612
-51% -$66.6M 0.02% 727
2014
Q3
$132M Sell
3,682,026
-1,037,682
-22% -$37.1M 0.05% 406
2014
Q2
$175M Buy
4,719,708
+2,970,002
+170% +$110M 0.07% 311
2014
Q1
$56.8M Sell
1,749,706
-532,376
-23% -$17.3M 0.02% 693
2013
Q4
$67.7M Buy
2,282,082
+301,886
+15% +$8.96M 0.03% 604
2013
Q3
$51.4M Buy
1,980,196
+129,816
+7% +$3.37M 0.02% 666
2013
Q2
$43.8M Buy
+1,850,380
New +$43.8M 0.02% 708